BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  Precision Optics Reports Fourth Quarter and Fiscal Year 2025 Financial Results

  September 29, 2025

   · 

  16 min read
• Press Releases

  Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates

  September 29, 2025

   · 

  10 min read
• Press Releases

  Soligenix Announces Closing of $7.5 Million Public Offering

  September 29, 2025

   · 

  7 min read
• Press Releases

  Arcutis Biotherapeutics to Host Virtual Investor Day and Report Third Quarter 2025 Financial Results on October 28, 2025

  September 29, 2025

   · 

  3 min read
• Press Releases

  Metsera Reports Positive Phase 2b Results for First- and Best-in-Class Ultra-long Acting GLP-1 RA Candidate MET-097i, Enabling Rapid Transition into Phase 3

  September 29, 2025

   · 

  13 min read
• Press Releases

  ARS Pharmaceuticals Secures Up to $250 Million Loan Facility with RA Capital Management and OMERS Life Sciences to Accelerate U.S. Commercialization of neffy®

  September 29, 2025

   · 

  13 min read
• Press Releases

  Kura Oncology and Kyowa Kirin Announce First Patient Dosed in Pivotal Phase 3 KOMET-017 Trial of Ziftomenib for Frontline Acute Myeloid Leukemia (AML)

  September 29, 2025

   · 

  7 min read
• Press Releases

  SciSparc: N2OFF Shareholders Approve Merger with SciSparc’s Majority Owned Subsidiary MitoCareX, a Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer

  September 29, 2025

   · 

  4 min read
• Press Releases

  Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting

  September 29, 2025

   · 

  5 min read
• Press Releases

  uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares

  September 29, 2025

   · 

  4 min read